LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. is a late-stage biopharmaceutical company focused on innovative therapies for presbyopia, an age-related vision condition. Its lead asset, eyedrop-based treatment LNZ100, offers a non-invasive alternative to reading glasses. Growth potential is tied to regulatory progress and market adoption of this vision correction approach. Chart
LKQ Corporation (LKQ)
LKQ Corporation is a leading provider of alternative and specialty automotive parts to repair and accessorize vehicles. The company’s diversified global footprint and focus on sustainability through recycled auto components support long-term growth. Demand is driven by aging vehicles and cost-conscious repair markets worldwide. Chart
Follow Trade Ideas on 